Abstract
Although the more striking histological feature in Hirschsprung’s disease is the absence of ganglion cells, it is unlikely that this is the only cause of the increased intestinal wall tone provoking a functional intestinal obstruction. In the first part of this chapter, we review the normal histological organization of the gut with the different cell types and their interaction accounting for intestinal motility. In the second part, we review the histopathological findings both in the aganglionic segment and in the proximal ganglionic segment in Hirschsprung’s disease which may account for the frequent discrepancy encountered between the length of the nonfunctional bowel and the degree of obstruction and also for the persistent obstructive symptoms after a pull-through operation for Hirschsprung’s disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Costa M, Brookes SJ, Hennig GW. Anatomy and physiology of the enteric nervous system. Gut. 2000;47 Suppl 4:iv15–9. discussion iv26
Olsson C, Holmgren S. The control of gut motility. Comp Biochem Physiol A Mol Integr Physiol. 2001;128(3):481–503.
Sanders K, Ward S, Koh S. Interstitial cells: regulators of smooth muscle function. Physiol Rev. 2014;94(3):859–907.
Takaki M. Gut pacemaker cells: the interstitial cells of Cajal (ICC). J Smooth Muscle Res. 2003;39(5):137–61.
Ward SM, Sanders KM, Hirst GD. Role of interstitial cells of Cajal in neural control of gastrointestinal smooth muscles. Neurogastroenterol Motil. 2004;16(Suppl 1):112–7.
Alberti E, et al. Motility patterns and distribution of interstitial cells of Cajal and nitrergic neurons in the proximal, mid- and distal-colon of the rat. Neurogastroenterol Motil. 2005;17(1):133–47.
Kurahashi M, et al. Platelet-derived growth factor receptor alpha-positive cells in the tunica muscularis of human colon. J Cell Mol Med. 2012;16(7):1397–404.
Berthoud HR, et al. Neuroanatomy of extrinsic afferents supplying the gastrointestinal tract. Neurogastroenterol Motil. 2004;16(Suppl 1):28–33.
Nagy N, Goldstein AM. Enteric nervous system development: a crest cell’s journey from neural tube to colon. Semin Cell Dev Biol. 2017;66:94–106.
Ganz J. Gut feelings: studying enteric nervous system development, function, and disease in the zebrafish model system. Dev Dyn. 2018;247(2):268–78.
Schemann M, Neunlist M. The human enteric nervous system. Neurogastroenterol Motil. 2004;16(Suppl 1):55–9.
Furness JB. Types of neurons in the enteric nervous system. J Auton Nerv Syst. 2000;81(1–3):87–96.
Bornstein JC, Furness JB, Kunze WA. Electrophysiological characterization of myenteric neurons: how do classification schemes relate? J Auton Nerv Syst. 1994;48(1):1–15.
Brehmer A, Schrodl F, Neuhuber W. Morphological classifications of enteric neurons – 100 years after Dogiel. Anat Embryol. 1999;200(2):125–35.
Costa M, et al. Neurochemical classification of myenteric neurons in the guinea-pig ileum. Neuroscience. 1996;75(3):949–67.
Clerc N, Furness JB. Intrinsic primary afferent neurones of the digestive tract. Neurogastroenterol Motil. 2004;16(Suppl 1):24–7.
Holzer P. Sensory neurone responses to mucosal noxae in the upper gut: relevance to mucosal integrity and gastrointestinal pain. Neurogastroenterol Motil. 2002;14(5):459–75.
Dockray GJ. Luminal sensing in the gut: an overview. J Physiol Pharmacol. 2003;54(Suppl 4):9–17.
Matini P, et al. Nitric oxide producing neurons in the human colon: an immunohistochemical and histoenzymatical study. Neurosci Lett. 1995;193(1):17–20.
Kunze WA, Furness JB. The enteric nervous system and regulation of intestinal motility. Annu Rev Physiol. 1999;61:117–42.
Vantrappen G, et al. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest. 1977;59(6):1158–66.
Summers RW, Dusdieker NS. Patterns of spike burst spread and flow in the canine small intestine. Gastroenterology. 1981;81(4):742–50.
Heuckeroth RO. Hirschsprung disease - integrating basic science and clinical medicine to improve outcomes. Nat Rev Gastroenterol Hepatol. 2018;15(3):152–67.
Meier-Ruge W, Bruder E. Histopathological diagnosis and differential diagnosis in Hirschsprung’s disease. In: Holschneider A, Puri P, editors. Hirschsprung’s disease and allied disorders. Berlin, Heidelberg: Springer; 2008. p. 185–94.
Kakita Y, et al. Selective demonstration of mural nerves in ganglionic and aganglionic colon by immunohistochemistry for glucose transporter-1: prominent extrinsic nerve pattern staining in Hirschsprung disease. Arch Pathol Lab Med. 2000;124(9):1314–9.
Kobayashi H, O’Briain DS, Puri P. Nerve growth factor receptor immunostaining suggests an extrinsic origin for hypertrophic nerves in Hirschsprung’s disease. Gut. 1994;35(11):1605–7.
Weinberg AG. Hirschsprung’s disease – a pathologist’s view. Perspect Pediatr Pathol. 1975;2:207–39.
Vizi ES, et al. Characteristics of cholinergic neuroeffector transmission of ganglionic and aganglionic colon in Hirschsprung’s disease. Gut. 1990;31(9):1046–50.
Boston VE, Cywes S, Davies MR. Serum and erythrocyte acetylcholinesterase activity in Hirschsprung’s disease. J Pediatr Surg. 1978;13(4):407–10.
Sato A, et al. Pathophysiology of aganglionic colon and anorectum: an experimental study on aganglionosis produced by a new method in the rat. J Pediatr Surg. 1978;13(4):399–435.
Nirasawa Y, et al. Hirschsprung’s disease: catecholamine content, alpha-adrenoceptors, and the effect of electrical stimulation in aganglionic colon. J Pediatr Surg. 1986;21(2):136–42.
Hiramoto Y, Kiesewetter WB. The response of colonic muscle to drugs: an in vitro study of Hirschsprung’s disease. J Pediatr Surg. 1974;9(1):13–20.
Kusafuka T, Puri P. Altered mRNA expression of the neuronal nitric oxide synthase gene in Hirschsprung’s disease. J Pediatr Surg. 1997;32(7):1054–8.
Bult H, et al. Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature. 1990;345(6273):346–7.
Nemeth L, Rolle U, Puri P. Altered cytoskeleton in smooth muscle of aganglionic bowel. Arch Pathol Lab Med. 2002;126(6):692–6.
Hope BT, et al. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci U S A. 1991;88(7):2811–4.
Kobayashi H, O’Briain DS, Puri P. Lack of expression of NADPH-diaphorase and neural cell adhesion molecule (NCAM) in colonic muscle of patients with Hirschsprung’s disease. J Pediatr Surg. 1994;29(2):301–4.
Bealer JF, et al. Effect of nitric oxide on the colonic smooth muscle of patients with Hirschsprung’s disease. J Pediatr Surg. 1994;29(8):1025–9.
Larsson LT, et al. Lack of neuronal nitric oxide synthase in nerve fibers of aganglionic intestine: a clue to Hirschsprung’s disease. J Pediatr Gastroenterol Nutr. 1995;20(1):49–53.
Rolle U, Nemeth L, Puri P. Nitrergic innervation of the normal gut and in motility disorders of childhood. J Pediatr Surg. 2002;37(4):551–67.
Vanderwinden JM, et al. Interstitial cells of Cajal in human colon and in Hirschsprung’s disease. Gastroenterology. 1996;111(4):901–10.
Yamataka A, et al. A lack of intestinal pacemaker (c-kit) in aganglionic bowel of patients with Hirschsprung’s disease. J Pediatr Surg. 1995;30(3):441–4.
Yamataka A, et al. Intestinal pacemaker C-KIT+ cells and synapses in allied Hirschsprung’s disorders. J Pediatr Surg. 1997;32(7):1069–74.
Horisawa M, Watanabe Y, Torihashi S. Distribution of c-Kit immunopositive cells in normal human colon and in Hirschsprung’s disease. J Pediatr Surg. 1998;33(8):1209–14.
Chen ZH, et al. Characterization of interstitial Cajal progenitors cells and their changes in Hirschsprung’s disease. PLoS One. 2014;9(1):e86100.
Rolle U, et al. Altered distribution of interstitial cells of Cajal in Hirschsprung disease. Arch Pathol Lab Med. 2002;126(8):928–33.
Gfroerer S, Rolle U. Interstitial cells of Cajal in the normal human gut and in Hirschsprung disease. Pediatr Surg Int. 2013;29(9):889–97.
Nemeth L, Maddur S, Puri P. Immunolocalization of the gap junction protein Connexin43 in the interstitial cells of Cajal in the normal and Hirschsprung’s disease bowel. J Pediatr Surg. 2000;35(6):823–8.
Coyle D, et al. Expression of connexin 26 and connexin 43 is reduced in Hirschsprung’s disease. J Surg Res. 2016;206(1):242–51.
Gomez-Pinilla P, et al. Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol. 2009;296(6):G1370–81.
Coyle D, et al. Use of anoctamin 1 (ANO1) to evaluate interstitial cells of Cajal in Hirschsprung’s disease. Pediatr Surg Int. 2016;32(2):125–33.
O’Donnell AM, Coyle D, Puri P. Deficiency of platelet-derived growth factor receptor-alpha-positive cells in Hirschsprung’s disease colon. World J Gastroenterol. 2016;22(12):3335–40.
Soeda J, O’Briain DS, Puri P. Mucosal neuroendocrine cell abnormalities in the colon of patients with Hirschsprung’s disease. J Pediatr Surg. 1992;27(7):823–7.
Covault J, Sanes JR. Distribution of N-CAM in synaptic and extrasynaptic portions of developing and adult skeletal muscle. J Cell Biol. 1986;102(3):716–30.
Romanska HM, et al. Increased expression of muscular neural cell adhesion molecule in congenital aganglionosis. Gastroenterology. 1993;105(4):1104–9.
Tennyson VM, et al. Distribution of hyaluronic acid and chondroitin sulfate proteoglycans in the presumptive aganglionic terminal bowel of ls/ls fetal mice: an ultrastructural analysis. J Comp Neurol. 1990;291(3):345–62.
Parikh DH, et al. Abnormalities in the distribution of laminin and collagen type IV in Hirschsprung’s disease. Gastroenterology. 1992;102(4 Pt 1):1236–41.
Parikh DH, et al. Quantitative and qualitative analysis of the extracellular matrix protein, laminin, in Hirschsprung’s disease. J Pediatr Surg. 1992;27(8):991–5; discussion 995–6
Parikh DH, et al. The extracellular matrix components, tenascin and fibronectin, in Hirschsprung’s disease: an immunohistochemical study. J Pediatr Surg. 1994;29(10):1302–6.
Soret R, et al. A collagen VI-dependent pathogenic mechanism for Hirschsprung’s disease. J Clin Invest. 2015;125(12):4483–96.
Rolig AS, et al. The enteric nervous system promotes intestinal health by constraining microbiota composition. PLoS Biol. 2017;15(2):e2000689.
Neuvonen MI, et al. Intestinal microbiota in Hirschsprung disease. J Pediatr Gastroenterol Nutr. 2018;67(5):594–600.
El-Sawaf M, et al. Probiotic prophylaxis after pullthrough for Hirschsprung disease to reduce incidence of enterocolitis: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. J Pediatr Surg. 2013;48(1):111–7.
Wang X, et al. Probiotics prevent Hirschsprung’s disease-associated enterocolitis: a prospective multicenter randomized controlled trial. Int J Colorectal Dis. 2015;30(1):105–10.
Nakamura H, Lim T, Puri P. Probiotics for the prevention of Hirschsprung-associated enterocolitis: a systematic review and meta-analysis. Pediatr Surg Int. 2018;34(2):189–93.
Menezes M, Corbally M, Puri P. Long-term results of bowel function after treatment for Hirschsprung’s disease: a 29-year review. Pediatr Surg Int. 2006;22(12):987–90.
Menezes M, et al. Long-term clinical outcome in patients with total colonic aganglionosis: a 31-year review. J Pediatr Surg. 2008;43(9):1696–9.
Mc Laughlin D, Friedmacher F, Puri P. Total colonic aganglionosis: a systematic review and meta-analysis of long-term clinical outcome. Pediatr Surg Int. 2012;28(8):773–9.
Puri P, Rolle U. Variant Hirschsprung’s disease. Semin Pediatr Surg. 2004;13(4):293–9.
Puri P, et al. Neuronal colonic dysplasia: an unusual association of Hirschsprung’s disease. J Pediatr Surg. 1977;12(5):681–5.
Fadda B, et al. Neuronal intestinal dysplasia. Critical 10-years’ analysis of clinical and biopsy diagnosis. Z Kinderchir. 1983;38(5):305–11.
Scharli AF. Intestinal neuronal dysplasia. Cir Pediatr. 1992;5(2):64–5.
Kobayashi H, et al. Intestinal neuronal dysplasia is a possible cause of persistent bowel symptoms after pull-through operation for Hirschsprung’s disease. J Pediatr Surg. 1995;30(2):253–7; discussion 257–9
Schmittenbecher PP, et al. Hirschsprung’s disease and intestinal neuronal dysplasia – a frequent association with implications for the postoperative course. Pediatr Surg Int. 1999;15(8):553–8.
Banani SA, Forootan HR, Kumar PV. Intestinal neuronal dysplasia as a cause of surgical failure in Hirschsprung’s disease: a new modality for surgical management. J Pediatr Surg. 1996;31(4):572–4.
Sandgren K, Larsson LT, Ekblad E. Widespread changes in neurotransmitter expression and number of enteric neurons and interstitial cells of Cajal in lethal spotted mice: an explanation for persisting dysmotility after operation for Hirschsprung’s disease? Dig Dis Sci. 2002;47(5):1049–64.
Swenson O, Rheinlander H, Diamond I. Hirschsprung’s disease: a new concept of the etiology. N Engl J Med. 1949;241:551–6.
Swenson O, Bill A. Resection of the rectum and rectosigmoid with preservation of the sphincter for benign spastic lesions producing megacolon. Surgery. 1948;24:212–20.
Kubota M, Ito Y, Ikeda K. Membrane properties and innervation of smooth muscle cells in Hirschsprung’s disease. Am J Physiol. 1983;244(4):G406–15.
Kubota M, et al. Regional differences in the pattern of neurogenic responses in the aganglionic colon from congenitally aganglionic rats. J Pediatr Surg. 1989;24(9):911–9.
Kubota M, et al. Electrophysiological properties of the aganglionic segment in Hirschsprung’s disease. Surgery. 2002;131(1 Suppl):S288–93.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
O’Donnell, A.M., Montedonico, S., Puri, P. (2019). Pathophysiology of Hirschsprung’s Disease. In: Puri, P. (eds) Hirschsprung's Disease and Allied Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-15647-3_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-15647-3_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-15646-6
Online ISBN: 978-3-030-15647-3
eBook Packages: MedicineMedicine (R0)